Medicilon appoints Dr Zhang Haizhou as President of Preclinical R&D Unit lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ On July 25, 2023, Fosun Health Capital established by Fosun Pharma (stock code:600196.SH), reached a strategic partnership with Medicilon.
/PRNewswire/ Medicilon, a leading one-stop pharmaceutical preclinical R&D service platform CRO, recently appointed Dr. Liu Jian as the President of Drug.
Medicilon Inc : Medicilon Appoints Dr Liu Jian as President of Drug Discovery Division finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Cadence Appoints Julia Liuson to Board of Directors
Cadence Appoints Julia Liuson to Board of Directors Cadence Design Systems, Inc. (Nasdaq: CDNS) today announced the appointment of Julia Liuson to its board of directors, effective January 4, 2021. Ms. Liuson is corporate vice president in the Developer Division at Microsoft Corporation, a leader in enabling the digital transformation for the era of an intelligent cloud and an intelligent edge. We are honored to welcome Julia Liuson to our board of directors, said John B. Shoven, Ph.D., Cadences chairman of the board. Cadences innovative solutions enable our customers to maximize the opportunities arising from generational industry trends, such as AI, hyperscale computing and data analytics. Julias deep technology and operational expertise coupled with her strong domain knowledge position her well to provide valuable strategic and technology guidance to accelerate Cadences Intelligent System Design strategy.